GSA 및 베넬룩스 현장진료검사(POCT) 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2032년까지의 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Healthcare Gsa And Benelux Point Care Testing Poct Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 무료 샘플 보고서 무료 샘플 보고서 구매하기 전에 문의 구매하기 전에 문의 지금 구매 지금 구매

GSA 및 베넬룩스 현장진료검사(POCT) 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2032년까지의 예측

  • Healthcare
  • Published Report
  • May 2025
  • Country Level
  • 350 Pages
  • 테이블 수: 710
  • 그림 수: 74
  • Author : Sachin Pawar
지금 구매 지금 구매 샘플요청 샘플요청
Nucleus Nucleus

민첩한 공급망 컨설팅으로 관세 문제를 극복하세요

공급망 생태계 분석이 이제 DBMR 보고서의 일부가 되었습니다

Gsa And Benelux Point Care Testing Poct Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Chart Image USD 3.63 Billion USD 9.07 Billion 2024 2032
Diagram 예측 기간
 2025 –2032
Diagram 시장 규모(기준 연도)
 USD 3.63 Billion
Diagram 시장 규모(예측 연도)
 USD 9.07 Billion
Diagram 연평균 성장률
 %
Diagram 주요 시장 플레이어
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Siemens Healthineers AG
  • Bio-Rad Laboratories Inc.
  • BIOMÉRIEUX

GSA 및 베네룩스 현장진단(POCT) 시장, 제품 유형별(포도당 모니터링 제품, 감염성 질환 검사 제품, 심장대사 모니터링 제품, 임신 및 생식력 검사 제품, 혈액학 검사 제품, 응고 모니터링 제품, 약물 남용(DOA) 검사 제품, 요분석 검사 제품, 콜레스테롤 검사 제품, 종양/암 마커 검사 제품, 분변 잠복 검사 제품 및 기타), 플랫폼별(측면 유동 분석/면역크로마토그래피 검사, 면역 분석, 딥스틱, 분자 진단, 임상 화학 분석, 미세유체역학, 혈액학, 기타), 응용 분야별(혈당, 감염성 질환, 생체 신호 모니터링, 심장 모니터링, 응고, 혈액학, 비침습적 SpO2 모니터링, 수혈, 비침습적 PCO2 모니터링, 전혈 분석, 기타), 처방 방식별(처방 기반 테스트 및 일반 의약품 테스트), 최종 사용자별(병원, 가정 간병, 진료소, 실험실, 진단 센터, 병리학 실험실, 외래 수술 센터, 노인 요양 센터, 기타), 유통 채널별(직접 입찰, 소매 판매, 온라인 판매 및 기타) - 2032년까지의 산업 동향 및 예측

 진료 시점 검사(POCT) 시장 규모

  • GSA 진료소 테스트(POCT) 시장 규모는 2024년에 36억 3천만 달러 로 평가되었으며 예측 기간 동안 12.1%의 CAGR 로 2032년까지 90억 7천만 달러 에 도달할 것으로 예상됩니다 .
  • 베넬룩스 POCT(Point-of-Care-Testing) 시장 규모는 2024년에 8억 8,200만 달러 로 평가되었으며 예측 기간 동안 9.5%의 CAGR 로 2032년까지 1,819백만 달러 에 도달할 것으로 예상됩니다 .
  • 이러한 성장은 신속한 진단 결과에 대한 수요 증가, 만성 및 감염성 질환의 유병률 증가, 휴대용 진단 기술의 발전과 같은 요인에 의해 촉진됩니다.

현장진료검사(POCT) 시장현장진료검사(POCT) 시장

진료 시점 검사(POCT) 시장 분석

  • 현장진단(POCT) 장비는 환자 진료 현장 또는 그 근처에서 신속한 진단 결과를 제공하는 데 중요한 역할을 하며, 다양한 의료 환경에서 임상적 의사결정을 크게 향상시킵니다. 이러한 검사는 만성 질환, 감염성 질환 및 응급 치료 관리에 널리 사용됩니다.
  • GSA 및 베넬룩스 지역의 POCT 솔루션 수요는 주로 만성 질환 부담 증가, 노인 인구 증가, 분산화 및 환자 중심 의료 모델에 대한 강력한 추진으로 인해 발생합니다.
  • 독일은 잘 구축된 의료 인프라, 높은 진단 처리량, 첨단 의료 기술 도입으로 인해 이 지역에서 28.04%의 점유율로 POCT 시장을 지배할 것으로 예상됩니다 .
  • 베넬룩스 국가들은 호의적인 정부 이니셔티브, 증가하는 의료비 지출, 임상 및 가정 치료 환경에서 POCT 도입 증가로 인해 강력한 시장 성장을 목격할 것으로 예상됩니다.
  • 혈당 검사 부문은 당뇨병의 높은 유병률과 질병 관리에 있어 환자를 지원하는 실시간 모니터링 도구에 대한 수요에 힘입어 시장 점유율 34.08%를 기록하며 이 지역 POCT 시장을 선도할 것으로 예상됩니다.

보고서 범위 및 진료 시점 테스트(POCT) 시장 세분화

속성

안과 수술 현미경 주요 시장 통찰력

다루는 세그먼트
  • 제품 유형별 : 포도당 모니터링 제품, 감염성 질환 검사 제품, 심장대사 모니터링 제품, 임신 및 생식 능력 검사 제품, 혈액학 검사 제품, 응고 모니터링 제품, 약물 남용(DOA) 검사 제품, 요분석 검사 제품, 콜레스테롤 검사 제품, 종양/암 마커 검사 제품, 분변 잠복 검사 제품 및 기타
  • 플랫폼별:  측면 흐름 분석/면역크로마토그래피 검사, 면역 분석, 딥스틱, 분자 진단, 임상 화학 분석, 미세유체역학, 혈액학 및 기타
  • 응용 분야별:  혈당, 감염성 질환, 생체 신호 모니터링, 심장 모니터링, 응고, 혈액학, 비침습적 SpO2 모니터링, 수혈, 비침습적 PCO2 모니터링, 전혈 분석 및 기타
  • 처방 모드별:  OTC 테스트, 처방 기반 테스트
  • 최종 사용자별:  병원, 재택 치료, 진료소, 실험실, 진단 센터, 병리학 실험실, 외래 수술 센터, 노인 요양 센터 및 기타
  • 유통채널별 : 직접입찰, 소매판매, 온라인판매 등

포함 국가

GSA

  • 독일
  • 스위스
  • 오스트리아

베네룩스

  • 벨기에
  • 네덜란드
  • 룩셈부르크

주요 시장 참여자
  • F. 호프만-라 로슈 유한회사(스위스)
  • 다나허 코퍼레이션(미국)
  • Siemens Healthineers AG(독일)
  • Bio-Rad Laboratories, Inc. (미국)
  • 비오메리유(프랑스)
  • BD(미국)
  • QuidelOrtho Corporation(미국)
  • Hologic, Inc. (미국)
  • Thermo Fisher Scientific Inc.(미국)
  • 애벗(미국)
  • 베르펜(스페인)
  • QIAGEN(독일)
  • 시스멕스 주식회사(일본)
  • EKF Diagnostics Holdings plc. (영국)
  • 세키스이 다이어그노스틱스(미국)
  • 메리디안 바이오사이언스(미국)
  • binx health, inc. (미국)
  • 트리니티 바이오텍(아일랜드)
  • 시엔코 주식회사(미국)
  • 아큐바이오텍 주식회사(중국)

시장 기회
  • 진료 시점 검사에 대한 인식 및 옹호 증가
  • 시장 참여자의 전략적 시작 및 결정

부가가치 데이터 정보 세트

Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 적용 범위, 주요 업체 등 시장 시나리오에 대한 통찰력 외에도 수입 수출 분석, 생산 능력 개요, 생산 소비 분석, 가격 추세 분석, 기후 변화 시나리오, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선택 기준, PESTLE 분석, Porter 분석 및 규제 프레임워크가 포함됩니다.

현장진료검사(POCT) 시장 동향

“GSA 및 베넬룩스 전역의 신속한 진단 및 분산 테스트의 발전”

  • GSA 및 베넬룩스 지역의 POCT 시장을 형성하는 한 가지 두드러진 추세는 진료 시점 장비에서 디지털 연결, 소형 센서 및 다중 테스트 기능의 통합이 증가하고 있다는 것입니다.
  • 이러한 혁신은 진단 속도와 정확도를 향상시켜 의료 서비스 제공자가 특히 응급 상황, 만성 질환 관리 및 감염성 질환 검진에서 시기적절한 결정을 내릴 수 있도록 합니다.
  • 예를 들어, 무선 데이터 전송 및 전자 건강 기록(EHR) 통합 기능을 갖춘 POCT 시스템은 독일과 네덜란드 전역의 1차 진료 시설에서 환자 모니터링을 간소화하고 병원 방문을 줄이기 위해 점점 더 많이 사용되고 있습니다.
  • 이러한 발전은 분산형 진단을 혁신하고 가치 기반 치료 모델을 지원하며 GSA 및 베넬룩스 지역 전체에서 환자 중심 의료로의 전환을 가속화하고 있습니다.
  • 예방 의료에 대한 강조가 높아지고 조기 질병 탐지에 대한 강력한 정부 지원이 결합되어 향상된 분석 성능과 사용성을 갖춘 차세대 POCT 솔루션에 대한 수요가 계속해서 증가하고 있습니다.

진료 시점 검사(POCT) 시장 동향

운전사

“의료 시설에서 POC 테스트 사용 증가”

  • 의료 시설에서 POC(Point-of-Care) 테스트 사용이 증가함에 따라 의료 서비스 제공자가 질병을 진단하고 관리하는 방식이 혁신되고 있습니다.
  • 빠르고 정확한 진단 결과에 대한 요구가 증가함에 따라 의료 전문가들은 환자 치료 개선을 위해 POC 검사를 도입하고 있습니다. 이러한 변화는 특히 신속한 의사 결정이 중요한 응급실, 외래 진료소, 진단 센터에서 두드러지게 나타납니다.
  • POC 테스트를 통해 의료 서비스 제공자는 진료 시점에 즉각적인 결과를 얻을 수 있으므로 환자가 실험실 결과를 기다릴 필요가 없으며 진단 및 치료 시간이 크게 단축됩니다.
  • 또한 POC 테스트는 휴대성이 뛰어나고 사용하기 편리하여 농촌 진료소부터 대형 병원까지 다양한 의료 환경에서 사용하기에 이상적입니다.
  • 만성 질환의 유병률 증가와 효율적인 의료 솔루션에 대한 수요 증가로 인해 POC 테스트 도입이 더욱 활발해지고 있습니다. 특히 당뇨병, 심혈관 질환, 감염성 질환과 같은 질환에서 POC 테스트는 질병 모니터링을 더욱 효과적으로 수행할 수 있게 해줍니다.
  • 의료 시설에서 이러한 기술을 워크플로에 점점 더 많이 통합함에 따라 진료 시점 테스트에 대한 수요도 계속해서 증가하고 있으며 이는 시장 확장의 핵심 동인으로 작용합니다.

예를 들어,

  • 2024년 3월, NCBI에 따르면 현장진단(POCT)의 빠른 처리 시간은 임상적 의사결정을 향상시키고, 관리 시간을 단축하며, 특히 응급실(ED)에서 환자 분류 효율성을 향상시킵니다. 현장진단(POCT)의 유연성은 병원 전 단계, 야전 병원, 재난 발생 시, 대규모 모임 또는 혼잡 지역에서도 활용될 수 있습니다.
  • 2024년 11월, OBJECTIVE Investment Banking & Valuation에서 발표한 기사에 따르면, 현장진료검사(POCT)로의 전환은 진단 결과를 환자 진료소로 직접 전달함으로써 의료 분야에 혁신을 가져왔습니다. POCT의 속도, 편의성, 효율성은 응급실, 외래 및 원격 진료 환경에서 매우 중요한 역할을 합니다. 신속한 진단에 대한 수요가 증가함에 따라
  • 의료 시설에서 현장진료(POC) 검사 도입이 증가하면서 질병 진단 및 관리 방식이 혁신되고 있습니다. 빠르고 정확한 검사 결과가 필요함에 따라 의료 서비스 제공자들은 환자 치료 개선을 위해 현장진료(POC) 검사를 활용하고 있습니다.

현장진료검사(POCT) 시장

기회

“진료소 검사에 대한 인식과 옹호가 높아지고 있습니다.”

  • 의료 전문가, 정책 입안자 및 일반 대중이 POCT의 이점(빠른 결과, 환자 관리 개선, 처리 시간 단축, 분산 테스트 가능성 등)에 대해 더 많이 알게 됨에 따라 이러한 솔루션에 대한 수요가 증가하고 있습니다.
  • 환자 그룹, 전문가 조직 및 산업 단체의 옹호 활동은 응급실, 1차 진료, 심지어 지역 사회 환경을 포함한 다양한 임상 환경에서 POCT의 가치를 더욱 강조합니다.
  • 이러한 이해와 지원의 증가는 POCT에 대한 투자 의지를 높이고 기존 의료 워크플로에 POCT를 통합하려는 의지를 더욱 강화하여 채택과 활용을 확대함으로써 시장 규모와 도달 범위를 확대합니다.

예를 들어,

  • 2023년 4월, NCBI는 독일 일반의(GP)의 압도적 다수(93%)가 현장진료검사(POCT)를 진료 현장에서 유용한 진단 도구로 여긴다고 밝혔습니다. 이들은 POCT 활용의 주요 이점으로 환자 관리에 대한 즉각적인 결정과 진단의 확실성 향상을 꼽았습니다.
  • Open Repository에서 발간한 "네덜란드 1차 진료에서의 진료 시점 검사"라는 제목의 기사에 따르면, 의료 전문가들은 치료 결정을 내리기 위해 진료 시점(POC) 진단 검사를 점점 더 많이 활용하고 있습니다. 이러한 검사의 주요 이점은 환자의 위치 또는 그 근처에서 빠른 결과를 얻을 수 있다는 것입니다.
  • 더욱이, 이러한 인식 제고와 지지는 POCT의 광범위한 시행을 지원하는 유리한 정책 변화와 자금 지원 계획으로 이어질 수 있습니다. GSA와 베네룩스의 정부와 의료 시스템은 POCT가 효율성과 진단 접근성을 향상시킬 수 있는 잠재력을 인식하고 이러한 기술 도입에 더 많은 자원을 할당할 수 있습니다.
  • 또한, 이러한 옹호 활동은 규제 기관이 혁신적인 현장진단(POCT) 기기의 승인 절차를 간소화하여 시장 진입을 가속화하도록 영향을 미칠 수 있습니다. 이는 시장 성장에 더욱 유리한 환경을 조성하여 기존 업체와 신규 진입 업체 모두 증가하는 수요를 충족하기 위해 첨단 현장진단(POCT) 솔루션 개발 및 구축에 투자하도록 장려합니다.

제지/도전

“데이터 보안 및 개인 정보 보호 문제”

  • 점점 더 많은 현장진단(POCT) 기기가 디지털 플랫폼과 통합됨에 따라, 민감한 환자 정보의 수집, 전송 및 저장은 무단 접근 및 데이터 유출 위험을 증가시킵니다. 개인 의료 정보를 포함하는 의료 데이터는 HIPAA 및 GDPR과 같은 법률에 따라 엄격한 보호가 요구되므로 제조업체와 의료 서비스 제공업체는 규정 준수에 있어 추가적인 복잡성을 겪게 됩니다.
  • 일부 POCT 장치에는 견고한 보안 프레임워크와 암호화 프로토콜이 없기 때문에 이러한 우려가 더욱 커집니다.
  • 더욱이, 개인정보 보호 위험으로 인해 환자들이 의료 데이터 공유를 주저하는 것은, 특히 디지털 헬스 솔루션에 대한 신뢰도가 낮은 지역에서 광범위한 도입을 저해할 수 있습니다. 안전하고 개인정보 보호를 준수하는 시스템의 지속적인 개발은 매우 중요하지만, 현재의 우려 사항들은 GSA 및 베네룩스 지역의 현장진단(POCT) 시장의 혁신 및 도입 속도를 둔화시키는 걸림돌로 작용하고 있습니다.

예를 들어,

  • MDPI가 게시한 블로그에 따르면, 2021년 7월 사이버 보안 및 개인정보 보호 위험과 관련하여 고려해야 할 중요한 측면 중 하나는 병원에서 널리 사용되고 있는 의료 현장진료(POC) 시스템입니다. POC 시스템은 데이터를 수집, 처리 및 시각화하기 위해 기기와 애플리케이션을 통합하는 플랫폼입니다. 개인 건강 정보와 민감한 의료 데이터가 포함된 방대한 양의 데이터가 다양한 POC 시스템, 백엔드 분석 플랫폼, 사용자 워크스테이션 및 스마트폰을 통해 통신됨에 따라, 환자의 생명에 해를 끼치는 데이터 유출이나 침해 사고를 유발하는 여러 위협이 존재함이 분명해지고 있습니다. 현장진료 검사는 데이터 유출에 취약하며, 이는 시장 성장을 저해하는 요인으로 작용합니다.
  • 데이터 보안 및 개인정보 보호 문제는 GSA 및 베네룩스 현장진단검사(POCT) 시장의 주요 과제입니다. 디지털 플랫폼에 연결되는 기기가 증가함에 따라, 특히 민감한 환자 정보와 관련된 무단 접근 및 데이터 유출 위험이 증가합니다. HIPAA 및 GDPR과 같은 규정 준수는 제조업체와 의료 서비스 제공업체의 복잡성을 가중시킵니다. 일부 기기의 강력한 보안 부족과 개인정보 보호에 대한 환자의 우려는 디지털 헬스케어 솔루션 도입을 지연시킬 수 있으며, 특히 디지털 헬스케어 솔루션에 대한 신뢰도가 낮은 지역에서는 더욱 그렇습니다. 이러한 장벽을 극복하기 위해서는 안전하고 개인정보 보호를 준수하는 시스템을 개발하는 것이 필수적입니다.

진료 시점 검사(POCT) 시장 범위

시장은 응용 프로그램, 제품 유형, 기술, 확대 유형, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다.

분할

하위 세분화

제품 유형별
  • 포도당 모니터링 제품
  • 감염병 검사 제품
  • 심장대사 모니터링 제품
  • 임신 및 임신 가능성 검사 제품
  • 혈액학 검사 제품
  • 응고 모니터링 제품
  • 약물 남용(DOA) 테스트 제품
  • 요분석 검사 제품
  • 콜레스테롤 검사 제품
  • 종양/암 표지자 검사 제품
  • 분변잠혈검사 제품
  • 기타

플랫폼별
  • 측면 흐름 분석/면역크로마토그래피 검사
  • 면역 검정법
  • 딥스틱
  • 분자 진단
  • 임상화학 검정
  • 미세유체학
  • 혈액학
  • 기타

응용 프로그램별
  • 혈당
  • 감염성 질환
  • 생명 징후 모니터링
  • 심장 모니터링
  • 응고
  • 혈액학
  • 비침습적 SpO2 모니터링
  • 수혈
  • 비침습적 PCO2 모니터링
  • 전혈 분석
  • 기타

처방 모드로

 
  • OTC 테스트
  • 처방 기반 테스트

최종 사용자별
  • 병원
  • 홈 케어 클리닉
  • 실험실
  • 진단 센터
  • 병리학 연구실
  • 외래 수술 센터
  • 노인 요양 시설
  • 기타

유통 채널별

 
  • 직접 입찰
  • 소매 판매
  • 온라인 판매
  • 기타

현장진료검사(POCT) 시장

2025년에는 포도당 모니터링 제품이 제품 유형 부문에서 가장 큰 점유율을 차지하며 시장을 지배할 것으로 예상됩니다.

당뇨병 유병률이 높고 편리하고 즉각적인 혈당 검사에 대한 필요성이 잦기 때문에 포도당 모니터링 제품 부문이 2025년에 34.08%의 가장 큰 점유율로 진료 시점 검사(POCT) 시장을 지배할 것으로 예상됩니다.

측면 흐름 분석/면역 크로마토그래피 테스트는 예측 기간 동안 플랫폼 세그먼트에서 가장 큰 점유율을 차지할 것으로 예상됩니다.

2025년에는 측면 흐름 분석/면역 크로마토그래피 테스트 부문이 간편성, 빠른 결과, 비용 효율성, 전통적인 실험실 환경 외의 광범위한 진단 응용 분야에 대한 적합성으로 인해 37.28%의 가장 큰 시장 점유율을 차지하며 시장을 지배할 것으로 예상됩니다.

진료 시점 검사(POCT) 시장 지역 분석

“독일은 POCT(Point-of-Care-Testing) 시장에서 가장 큰 점유율을 차지하고 있습니다.”

  • 독일은 GSA 지역 내 POCT(Point-of-Care Testing) 시장을 82.06%의 점유율로 장악하고 있으며 , 이는 고도로 발달된 의료 인프라, 혁신적인 진단 기술의 광범위한 채택, 예방 및 개인화 의학에 대한 강력한 강조에 힘입은 것입니다.
  • 이 나라는 특히 당뇨병, 심혈관 질환, 호흡기 감염과 같은 만성 질환을 관리하는 데 있어 신속하고 정확한 진단 솔루션에 대한 수요가 증가함에 따라 상당한 점유율을 차지하고 있습니다.
  • 지원적 보상 프레임워크, 정부 지원 디지털 건강 이니셔티브, 그리고 의료 R&D에 대한 강력한 투자는 시장 성장을 더욱 촉진합니다.
  • 또한, 응급실, 1차 진료 시설 및 가정 의료에서 ​​POCT 구현이 증가하고 병원 부담을 줄이는 데 중점을 두면서 독일 전역에서 시장 확장이 가속화되고 있습니다.

“네덜란드는 POCT(Point-of-Care-Testing) 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.”

  • 네덜란드는 디지털 헬스케어, 조기 질병 탐지, 환자 중심 치료 모델에 대한 강력한 집중으로 인해 POCT(Point-of-Care Testing) 시장에서 54.40%의 점유율을 기록하며 강력한 성장을 보일 것으로 예상됩니다.
  • 국가의 고령화 인구와 당뇨병, 심혈관 질환, 호흡기 질환과 같은 만성 질환의 유병률 증가로 인해 신속하고 분산화된 진단 솔루션에 대한 수요가 증가하고 있습니다.
  • 잘 확립된 1차 의료 시스템과 진보적인 의료 정책을 갖춘 네덜란드는 특히 지역 사회 건강 환경, 일반의(GP) 진료소 및 가정 간병 서비스 분야에서 POCT 기술의 주요 도입국으로 남아 있습니다.
  • POCT 장치와 전자 건강 기록(EHR)의 통합 증가, 진단 혁신을 위한 건강 보험사의 지원, EU 전역의 건강 기술 이니셔티브에 대한 적극적인 참여로 시장 전망이 더욱 강화되고 있습니다.
  • 학계 기관, 기술 스타트업 및 진단 회사 간의 협업을 통해 네덜란드 의료 시스템에 맞춰진 고급 사용자 친화적 POCT 솔루션의 혁신과 현지 개발이 가속화되고 있습니다.

진료 시점 검사(POCT) 시장 점유율

시장 경쟁 구도는 경쟁사별 세부 정보를 제공합니다. 여기에는 회사 개요, 회사 재무 상태, 매출 창출, 시장 잠재력, 연구 개발 투자, 신규 시장 진출, 글로벌 입지, 생산 시설 및 설비, 생산 능력, 회사의 강점과 약점, 제품 출시, 제품 종류 및 범위, 응용 분야별 우위 등이 포함됩니다. 위에 제공된 데이터는 해당 회사의 시장 집중도와 관련된 데이터입니다.

시장에서 활동하는 주요 시장 리더는 다음과 같습니다.

  • F. 호프만-라 로슈 유한회사(스위스)
  • 다나허 코퍼레이션(미국)
  • Siemens Healthineers AG(독일)
  • Bio-Rad Laboratories, Inc. (미국)
  • 비오메리유(프랑스)
  • BD(미국)
  • QuidelOrtho Corporation(미국)
  • Hologic, Inc. (미국)
  • Thermo Fisher Scientific Inc.(미국)
  • 애벗(미국)
  • 베르펜(스페인)
  • QIAGEN(독일)
  • 시스멕스 주식회사(일본)
  • EKF Diagnostics Holdings plc. (영국)
  • 세키스이 다이어그노스틱스(미국)
  • 메리디안 바이오사이언스(미국)
  • binx health, inc. (미국)
  • 트리니티 바이오텍(아일랜드)
  • 시엔코 주식회사(미국)
  • 아큐바이오텍 주식회사(중국)

GSA 및 베넬룩스 현장진단(POCT) 시장의 최신 동향

  • 2023년 12월, 로슈는 루미라Dx의 혁신적인 현장진료(Point of Care) 기술 중 일부를 인수하여 진단 포트폴리오를 강화했습니다. 이번 인수를 통해 다양한 질병 영역에서 더 빠르고 저렴한 검사가 가능해졌습니다. 루미라Dx 플랫폼 통합을 통해 전 세계 분산형 의료 환경에서 환자들이 시의적절하고 정확한 진단 결과에 더 쉽게 접근할 수 있게 될 것입니다.
  • 2025년 1월, Danaher Corporation은 헬스케어 AI 기업인 Innovaccer Inc.와 투자 파트너십을 체결했습니다. 이 협력은 의료 서비스 제공자에게 통합된 환자 데이터와 고급 분석을 제공하고, 개인 맞춤형 시의적절한 개입을 통해 환자 치료 결과를 개선함으로써 정밀 진단 및 가치 기반 치료 도입을 가속화하는 것을 목표로 합니다.
  • 2024년 10월, 비오메리외(bioMérieux)는 항생제 내성(AMR)에 대한 글로벌 의제를 발전시키기 위한 다부문 협력을 촉구했습니다. 비오메리외는 항생제 내성(AMR) 문제를 해결하기 위해 의료, 정부, 그리고 업계의 공동 노력이 시급함을 강조하며, 혁신적인 진단 솔루션과 책임감 있는 항생제 사용을 장려하여 이러한 증가하는 세계적 보건 위협에 맞서야 한다고 강조했습니다.
  • 2024년 3월, Bio-Rad는 신속하고 정확한 식품 안전 검사를 위한 XP-Design Assay Salmonella 혈청형 분석 솔루션을 출시했습니다. XP-Design Assay Salmonella 혈청형 분석 솔루션은 초기 스크리닝 후 살모넬라 혈청형을 식별하는 유연한 접근 방식을 제공했습니다. 즉시 사용 가능한 이 솔루션에는 표적 혈청형에 특이적인 올리고뉴클레오타이드(프라이머 및 프로브)가 포함되어 있어 높은 특이도를 보장하고 교차 반응 위험을 줄여 신뢰할 수 있는 결과를 제공합니다. 

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 YEARS CONSIDERED FOR THE STUDY

2.3 CURRENCY AND PRICING

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 MULTIVARIATE MODELLING

2.6 PRODUCT TYPE LIFELINE CURVE

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 MICRO AND MACRO ECONOMIC FACTORS

4.4 PENETRATION AND GROWTH PROSPECT MAPPING

4.5 KEY PRICING STRATEGIES

4.6 COST ANALYSIS BREAKDOWN

4.7 OPPORTUNITY MAP ANALYSIS

4.8 VALUE CHAIN ANALYSIS

4.9 HEALTHCARE ECONOMY

4.1 TARIFFS

4.10.1 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR

4.10.2 GLOBAL VS. REGIONAL TARIFF STRUCTURES

4.10.3 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY

4.10.4 TARIFF REGULATIONS IN KEY MARKETS

4.10.4.1 MEDICARE/MEDICAID TARIFF POLICIES

4.10.4.2 CMS PRICING MODELS

4.10.4.3 OTHERS

4.10.5 TARIFFS ON MEDICAL DEVICES & EQUIPMENT

4.10.5.1 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT

4.10.5.2 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY

4.10.5.3 CASE STUDIES OF TARIFF CHANGES AFFECTING THE INDUSTRY

4.10.6 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES

4.10.7 TARIFF EXEMPTIONS AND INCENTIVES

4.10.8 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES

4.10.9 16.9 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN

4.10.10 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS

5 CUSTOMIZATION

5.1 LEADING DIGITAL HEALTH PLATFORMS IN EACH COUNTRY –

5.2 POCT DATA INTEGRATION USE CASES –

5.3 INFORMATICS PLATFORMS & TELEMEDICINE INTEGRATION:

6 REGULATORY

6.1 REGULATORY GSA

6.2 REGULATORY BENELUX

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES

7.1.2 RISING INCIDENCE OF SUBSTANCE ABUSE

7.1.3 INCREASED ADOPTION OF TELEMEDICINE

7.1.4 ADVANCEMENTS TECHNOLOGIES ENHANCING POC TESTING WITH BIOSENSORS AND MOBILE INTEGRATION

7.2 RESTRAINTS

7.2.1 DATA SECURITY AND PRIVACY CONCERNS

7.2.2 ACCURACY LIMITATIONS AND TECHNICAL BARRIERS

7.3 OPPORTUNITIES

7.3.1 RISING AWARENESS AND ADVOCACY FOR POINT-OF-CARE TESTING

7.3.2 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS

7.3.3 EXPANDING PRODUCT RANGE FOR POINT-OF-CARE TESTING

7.4 CHALLENGES

7.4.1 LIMITED AWARENESS AND ACCEPTANCE OF POINT-OF-CARE (POC) TESTING

7.4.2 IMPACT OF HIGH MAINTENANCE COSTS THREATEN POINT-OF-CARE TESTING (POCT) SUSTAINABILITY IN LOW-RESOURCE SETTINGS

 

8 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 GLUCOSE MONITORING PRODUCTS

8.2.1 STRIPS

8.2.2 METERS

8.2.3 LANCETS AND LANCING DEVICES

8.3 INFECTIOUS DISEASE TESTING PRODUCTS

8.3.1 COVID-19

8.3.2 HIV TESTING PRODUCTS

8.3.2.1 TESTING REAGENTS

8.3.2.2 TESTING EQUIPMENT

8.3.3 RESPIRATORY INFECTION TESTING PRODUCTS

8.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING

8.3.4.1 NAAT-BASED SYSTEMS

8.3.4.2 NON–NAAT-BASED SYSTEMS

8.3.5 HEPATITIS C TESTING PRODUCTS

8.3.5.1 HCV ANTIBODY TESTS

8.3.5.2 HCV VIRAL LOAD TESTS

8.3.6 INFLUENZA TESTING PRODUCTS

8.3.6.1 TRADITIONAL DIAGNOSTIC TEST

8.3.6.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)

8.3.6.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)

8.3.6.1.3 VIRAL CULTURE

8.3.6.1.4 SEROLOGICAL ASSAY

8.3.6.2 MOLECULAR DIAGNOSTIC ASSAY

8.3.6.2.1 RT-PCR

8.3.6.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)

8.3.6.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)

8.3.6.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)

8.3.7 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING

8.3.8 TROPICAL DISEASE TESTING PRODUCTS

8.3.9 OTHER INFECTIOUS DISEASE TESTING PRODUCTS

 

8.4 CARDIOMETABOLIC MONITORING PRODUCTS

8.4.1 CARDIAC MARKER TESTING PRODUCTS

8.4.1.1 HSTNL

8.4.1.2 BNP

8.4.1.3 D-DIMER

8.4.1.4 CK-MB

8.4.1.5 MYOGLOBIN

8.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS

8.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES

8.4.3.1 CARTRIDGES

8.4.3.2 REAGENTS

8.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS

8.4.4.1 PORTABLE

8.4.4.1.1 COMBINED ANALYZERS

8.4.4.1.2 BLOOD GAS ANALYZERS

8.4.4.1.3 ELECTROLYTE ANALYZERS

8.4.4.2 BENCHTOP

8.4.4.2.1 COMBINED ANALYZERS

8.4.4.2.2 BLOOD GAS ANALYZERS

8.4.4.2.3 ELECTROLYTE ANALYZERS

8.4.5 HBA1C TESTING PRODUCTS

8.4.5.1 HBA1C TESTING INSTRUMENTS

8.4.5.2 HBA1C TESTING CONSUMABLES

8.4.6 POC ANALYZER

8.4.7 ECG DEVICE

8.4.7.1 RESTING ECG DEVICES

8.4.7.2 STRESS ECG DEVICES

8.4.7.3 HOLTER MONITORS

8.5 PREGNANCY AND FERTILITY TESTING PRODUCTS

8.5.1 PREGNANCY TESTING PRODUCTS

8.5.1.1 STRIPS/ DIP STICKS AND CARDS

8.5.1.2 MID STREAM DEVICES

8.5.1.3 CASSETTES

8.5.1.4 DIGITAL DEVICES

8.5.1.5 LINE-INDICATOR DEVICES

8.5.2 FERTILITY TESTING PRODUCTS

8.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST

8.5.2.2 FSH TEST

8.5.2.3 OTHERS

 

8.6 HAEMATOLOGY TESTING PRODUCTS

8.7 COAGULATION MONITORING PRODUCTS

8.7.1 ANTICOAGULATION MONITORING DEVICES

8.7.1.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES

8.7.1.2 ACTIVATED CLOTTING TIME (ACT)

8.7.1.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)

8.7.2 PLATELET FUNCTION MONITORING DEVICES

8.7.3 VISCOELASTIC COAGULATION MONITORING DEVICES

8.7.3.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)

8.7.3.2 THROMBOELASTOGRAPHY (TEG)

8.8 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS

8.8.1 DOA ANALYSERS

8.8.1.1 IMMUNOASSAYS

8.8.1.2 CHROMATOGRAPHIC DEVICES

8.8.1.3 BREATH ANALYSERS

8.8.2 RAPID TESTING DEVICES

8.8.2.1 URINE TESTING DEVICES

8.8.2.2 ORAL FLUID TESTING DEVICES

8.8.2.3 OTHERS

8.9 URINALYSIS TESTING PRODUCTS

8.9.1 POC URINE STRIP SELF-TESTING

8.9.2 POC URINE TEST STRIP PROFESSIONAL TESTING

8.1 CHOLESTEROL TESTING PRODUCTS

8.10.1 TESTING KITS

8.10.2 INSTRUMENTS

8.10.2.1 TABLE-TOP ANALYZERS

8.10.2.2 HAND-HELD ANALYZERS

8.11 TUMOR/CANCER MARKER TESTING PRODUCTS

8.12 FECAL OCCULT TESTING PRODUCTS

8.12.1 GUAIAC FOB STOOL TEST

8.12.2 LATERAL FLOW IMMUNO-FOB TEST

8.12.3 IMMUNO-FOB AGGLUTINATION TEST

8.12.4 IMMUNO-FOB ELISA TEST

8.13 OTHERS

 

9 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE

9.1 OVERVIEW

9.2 OTC TESTING

9.3 PRESCRIPTION-BASED TESTING

10 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM

10.1 OVERVIEW

10.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS

10.3 IMMUNOASSAYS

10.4 DIPSTICKS

10.5 MOLECULAR DIAGNOSTICS

10.6 CLINICAL CHEMISTRY ASSAYS

10.7 MICROFLUIDICS

10.8 HEMATOLOGY

10.9 OTHERS

11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 BLOOD GLUCOSE

11.3 INFECTIOUS DISEASES

11.3.1 COVID-19 TESTING

11.3.2 HIV TESTING

11.3.3 HEPATITIS C TESTING

11.3.4 INFLUENZA TESTING

11.3.5 TUBERCULOSIS TESTING

11.3.6 OTHERS

11.4 VITAL SIGN MONITORING

11.5 CARDIAC MONITORING

11.6 COAGULATION

11.7 HAEMATOLOGY

11.8 NON- INVASIVE SPO2 MONITORING

11.9 BLOOD TRANSFUSION

11.1 NON- INVASIVE PCO2 MONITORING

11.11 WHOLE BLOOD ANALYSIS

11.12 OTHERS

 

12 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 PRIVATE

12.2.1.1 TIER 1

12.2.1.2 TIER 2

12.2.1.3 TIER 3

12.2.2 PUBLIC

12.3 HOME CARE

12.4 CLINICS

12.5 LABORATORIES

12.6 DIAGNOSTIC CENTERS

12.7 PATHOLOGY LABS

12.8 AMBULATORY SURGERY CENTERS

12.9 ELDERLY CARE CENTERS

12.1 OTHERS

13 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 RETAIL SALES

13.4 ONLINE SALES

13.5 OTHERS

14 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE

14.1 OVERVIEW

14.2 GLUCOSE MONITORING PRODUCTS

14.2.1 STRIPS

14.2.2 METERS

14.2.3 LANCETS AND LANCING DEVICES

14.3 INFECTIOUS DISEASE TESTING PRODUCTS

14.3.1 COVID-19

14.3.2 HIV TESTING PRODUCTS

14.3.2.1 TESTING REAGENTS

14.3.2.2 TESTING EQUIPMENT

14.3.3 RESPIRATORY INFECTION TESTING PRODUCTS

14.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING

14.3.5 NAAT-BASED SYSTEMS

14.3.6 NON–NAAT-BASED SYSTEMS

14.3.7 HEPATITIS C TESTING PRODUCTS

14.3.7.1 HCV ANTIBODY TESTS

14.3.7.2 HCV VIRAL LOAD TESTS

14.3.8 INFLUENZA TESTING PRODUCTS

14.3.8.1 TRADITIONAL DIAGNOSTIC TEST

14.3.8.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)

14.3.8.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)

14.3.8.1.3 VIRAL CULTURE

14.3.8.1.4 SEROLOGICAL ASSAY

14.3.8.2 MOLECULAR DIAGNOSTIC ASSAY

14.3.8.2.1 RT-PCR

14.3.8.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)

14.3.8.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)

14.3.8.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)

14.3.9 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING

14.3.10 TROPICAL DISEASE TESTING PRODUCTS

14.3.11 OTHER INFECTIOUS DISEASE TESTING PRODUCTS

14.4 CARDIOMETABOLIC MONITORING PRODUCTS

14.4.1 CARDIAC MARKER TESTING PRODUCTS

14.4.1.1 HSTNL

14.4.1.2 BNP

14.4.1.3 D-DIMER

14.4.1.4 CK-MB

14.4.1.5 MYOGLOBIN

14.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS

14.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES

14.4.3.1 CARTRIDGES

14.4.3.2 REAGENTS

14.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS

14.4.5 PORTABLE

14.4.5.1 COMBINED ANALYZERS

14.4.5.2 BLOOD GAS ANALYZERS

14.4.5.3 ELECTROLYTE ANALYZERS

14.4.6 BENCHTOP

14.4.6.1 COMBINED ANALYZERS

14.4.6.2 BLOOD GAS ANALYZERS

14.4.6.3 ELECTROLYTE ANALYZERS

14.4.7 HBA1C TESTING PRODUCTS

14.4.7.1 HBA1C TESTING INSTRUMENTS

14.4.7.2 HBA1C TESTING CONSUMABLES

14.4.8 POC ANALYZER

14.4.9 ECG DEVICE

14.4.9.1 RESTING ECG DEVICES

14.4.9.2 STRESS ECG DEVICES

14.4.9.3 HOLTER MONITORS

14.5 PREGNANCY AND FERTILITY TESTING PRODUCTS

14.5.1 PREGNANCY TESTING PRODUCTS

14.5.1.1 STRIPS/ DIP STICKS AND CARDS

14.5.1.2 MID STREAM DEVICES

14.5.1.3 CASSETTES

14.5.1.4 DIGITAL DEVICES

14.5.1.5 LINE-INDICATOR DEVICES

14.5.2 FERTILITY TESTING PRODUCTS

14.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST

14.5.2.2 FSH TEST

14.5.2.3 OTHERS

14.6 HAEMATOLOGY TESTING PRODUCTS

14.7 COAGULATION MONITORING PRODUCTS

14.8 ANTICOAGULATION MONITORING DEVICES

14.8.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES

14.8.2 ACTIVATED CLOTTING TIME (ACT)

14.8.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)

14.8.4 PLATELET FUNCTION MONITORING DEVICES

14.8.5 VISCOELASTIC COAGULATION MONITORING DEVICES

14.8.5.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)

14.8.5.2 THROMBOELASTOGRAPHY (TEG)

14.9 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS

14.9.1 DOA ANALYSERS

14.9.1.1 IMMUNOASSAYS

14.9.1.2 CHROMATOGRAPHIC DEVICES

14.9.1.3 BREATH ANALYSERS

14.9.2 RAPID TESTING DEVICES

14.9.2.1 URINE TESTING DEVICES

14.9.2.2 ORAL FLUID TESTING DEVICES

14.9.3 OTHERS

14.1 URINALYSIS TESTING PRODUCTS

14.10.1 POC URINE STRIP SELF-TESTING

14.10.2 POC URINE TEST STRIP PROFESSIONAL TESTING

 

14.11 CHOLESTEROL TESTING PRODUCTS

14.11.1 TESTING KITS

14.11.2 INSTRUMENTS

14.11.2.1 TABLE-TOP ANALYZERS

14.11.2.2 HAND-HELD ANALYZERS

14.12 TUMOR/CANCER MARKER TESTING PRODUCTS

14.13 FECAL OCCULT TESTING PRODUCTS

14.13.1 GUAIAC FOB STOOL TEST

14.13.2 LATERAL FLOW IMMUNO-FOB TEST

14.13.3 IMMUNO-FOB AGGLUTINATION TEST

14.13.4 IMMUNO-FOB ELISA TEST

14.14 OTHERS

15 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM

15.1 OVERVIEW

15.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS

15.3 IMMUNOASSAYS

15.4 DIPSTICKS

15.5 MOLECULAR DIAGNOSTICS

15.6 CLINICAL CHEMISTRY ASSAYS

15.7 MICROFLUIDICS

15.8 HEMATOLOGY

15.9 OTHERS

16 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE

16.1 OVERVIEW

16.2 OTC TESTING

16.3 PRESCRIPTION-BASED TESTING

17 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION

17.1 OVERVIEW

17.2 BLOOD GLUCOSE

17.3 INFECTIOUS DISEASES

17.3.1.1 COVID-19 TESTING

17.3.1.2 HIV TESTING

17.3.1.3 HEPATITIS C TESTING

17.3.1.4 INFLUENZA TESTING

17.3.1.5 TUBERCULOSIS TESTING

17.3.1.6 OTHERS

17.4 VITAL SIGN MONITORING

17.5 CARDIAC MONITORING

17.6 COAGULATION

17.7 HAEMATOLOGY

17.8 NON- INVASIVE SPO2 MONITORING

17.9 BLOOD TRANSFUSION

17.1 NON- INVASIVE PCO2 MONITORING

17.11 WHOLE BLOOD ANALYSIS

17.12 OTHERS

18 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY END USER

18.1 OVERVIEW

18.2 HOSPITALS

18.2.1 PRIVATE

18.2.1.1 TIER 1

18.2.1.2 TIER 2

18.2.1.3 TIER 3

18.2.2 PUBLIC

18.3 HOME CARE

18.4 CLINICS

18.5 LABORATORIES

18.6 DIAGNOSTIC CENTERS

18.7 PATHOLOGY LABS

18.8 AMBULATORY SURGERY CENTERS

18.9 ELDERLY CARE CENTERS

18.1 OTHERS

19 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL

19.1 OVERVIEW

19.2 DIRECT TENDER

19.3 RETAIL SALES

19.4 ONLINE SALES

19.5 OTHERS

20 GSA & BENELUX

20.1 GERMANY

20.2 NETHERLANDS

20.3 SWITZERLAND

20.4 BELGIUM

20.5 AUSTRIA

20.6 LUXEMBOURG

21 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY LANDSCAPE

21.1 COMPANY SHARE ANALYSIS: GSA AND BENELUX

22 SWOT ANALYSIS

23 COMPANY PROFILE

23.1 F. HOFFMANN-LA ROCHE LTD

23.1.1 COMPANY SNAPSHOT

23.1.2 REVENUE ANALYSIS

23.1.3 PRODUCT PORTFOLIO

23.1.4 RECENT DEVELOPMENT

23.2 DANAHER CORPORATION

23.2.1 COMPANY SNAPSHOT

23.2.2 REVENUE ANALYSIS

23.2.3 PRODUCT PORTFOLIO

23.2.4 RECENT DEVELOPMENT

23.3 SIEMENS HEALTHINEERS AG

23.3.1 COMPANY SNAPSHOT

23.3.2 REVENUE ANALYSIS

23.3.3 PRODUCT PORTFOLIO

23.3.4 RECENT DEVELOPMENT

23.4 BIO- RAD LABORATORIES, INC.

23.4.1 COMPANY SNAPSHOT

23.4.2 REVENUE ANALYSIS

23.4.3 PRODUCT PORTFOLIO

23.4.4 RECENT DEVELOPMENT

23.5 BIOMERIEUX

23.5.1 COMPANY SNAPSHOT

23.5.2 REVENUE ANALYSIS

23.5.3 PRODUCT PORTFOLIO

23.5.4 RECENT DEVELOPMENT

23.6 ACCUBIOTECH CO., LTD.

23.6.1 COMPANY SNAPSHOT

23.6.2 PRODUCT PORTFOLIO

23.6.3 RECENT DEVELOPMENT

 

23.7 ABBOTT

23.7.1 COMPANY SNAPSHOT

23.7.2 REVENUE ANALYSIS

23.7.3 PRODUCT PORTFOLIO

23.7.4 RECENT DEVELOPMENT/NEWS

23.8 BINX HEALTH

23.8.1 COMPANY SNAPSHOT

23.8.2 SOLUTION PORTFOLIO

23.8.3 RECENT DEVELOPMENT

23.9 BD

23.9.1 COMPANY SNAPSHOT

23.9.2 REVENUE ANALYSIS

23.9.3 PRODUCT PORTFOLIO

23.9.4 RECENT DEVELOPMENT/NEWS

23.1 EKF DIAGNOSTICS HOLDINGS PLC

23.10.1 COMPANY SNAPSHOT

23.10.2 REVENUE ANALYSIS

23.10.3 PRODUCT PORTFOLIO

23.10.4 RECENT DEVELOPMENT

23.11 HOLOGIC, INC

23.11.1 COMPANY SNAPSHOT

23.11.2 REVENUE ANALYSIS

23.11.3 PRODUCT PORTFOLIO

23.11.4 RECENT DEVELOPMENT

23.12 MERIDIAN BIOSCIENCE, INC.

23.12.1 COMPANY SNAPSHOT

23.12.2 PRODUCT PORTFOLIO

23.12.3 RECENT DEVELOPMENT/NEWS

23.13 QIAGEN

23.13.1 COMPANY SNAPSHOT

23.13.2 REVENUE ANALYSIS

23.13.3 PRODUCT PORTFOLIO

23.13.4 RECENT DEVELOPMENT

23.14 QUIDELORTHO CORPORATION

23.14.1 COMPANY SNAPSHOT

23.14.2 REVENUE ANALYSIS

23.14.3 PRODUCT PORTFOLIO

23.14.4 RECENT DEVELOPMENT

 

23.15 SEKISUI DIAGNOSTICS

23.15.1 COMPANY SNAPSHOT

23.15.2 PRODUCT PORTFOLIO

23.15.3 RECENT DEVELOPMENT

23.16 SYSMEX CORPORATION

23.16.1 COMPANY SNAPSHOT

23.16.2 REVENUE ANALYSIS

23.16.3 PRODUCT PORTFOLIO

23.16.4 RECENT DEVELOPMENT

23.17 SIENCO, INC.

23.17.1 COMPANY SNAPSHOT

23.17.2 PRODUCT PORTFOLIO

23.17.3 RECENT DEVELOPMENT

23.18 TRINITY BIOTECH

23.18.1 COMPANY SNAPSHOT

23.18.2 REVENUE ANALYSIS

23.18.3 PRODUCT PORTFOLIO

23.18.4 RECENT DEVELOPMENT

23.19 THERMO FISHER SCIENTIFIC INC.

23.19.1 COMPANY SNAPSHOT

23.19.2 REVENUE ANALYSIS

23.19.3 PRODUCT PORTFOLIO

23.19.4 RECENT DEVELOPMENT

23.2 WERFEN

23.20.1 COMPANY SNAPSHOT

23.20.2 PRODUCT PORTFOLIO

23.20.3 RECENT DEVELOPMENT

24 QUESTIONNAIRE

표 목록

TABLE 1 HOME-USE POCT DEVICES WITH TELEMEDICINE INTEGRATION

TABLE 2 COMPANIES AND PRODUCTS WITH TELEMEDICINE INTEGRATION

TABLE 3 A TECHNOLOGY ROADMAP OUTLINING THE FUTURE OF CONNECTED POCT DEVICES

TABLE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 5 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 6 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 7 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 8 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 9 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 10 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 11 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 12 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 13 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 14 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 15 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 16 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 17 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 18 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 19 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 20 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 21 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 22 GSA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 23 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 24 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 25 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 26 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 27 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 28 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 29 GSA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 30 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 31 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 32 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 33 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 34 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 35 GSA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 36 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 37 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 38 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 39 GSA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 40 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 41 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 42 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 43 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 45 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 46 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 47 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 48 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 49 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 51 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 52 GSA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 53 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 54 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 55 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 56 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 58 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 59 GSA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 60 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 61 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 62 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 63 GSA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 64 GSA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 65 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 66 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)

TABLE 67 GSA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 68 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 70 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 71 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 72 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 73 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 74 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 76 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 77 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 79 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 80 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 82 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 83 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 84 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 85 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 86 GSA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 87 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 88 GSA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 GSA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 90 GSA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 91 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 92 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 93 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 94 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 95 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 96 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 97 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 98 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 99 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 100 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 101 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 102 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 103 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 104 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 106 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 107 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 108 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 109 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 110 BENELUX INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 112 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 113 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 114 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 115 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 116 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 117 BENELUX CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 119 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 120 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 121 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 122 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 123 BENELUX BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 124 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 125 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 126 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 127 BENELUX BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 129 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 130 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 131 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 132 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 133 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 134 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 135 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 136 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 137 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 138 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 139 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 140 BENELUX PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 142 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 143 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 144 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 145 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 146 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 147 BENELUX COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 148 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 149 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 150 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 151 BENELUX VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 152 BENELUX DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)

TABLE 155 BENELUX DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 156 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 157 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 158 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 159 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 160 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 161 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 162 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 163 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 164 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 165 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 166 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 167 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 168 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 169 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 170 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 171 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 172 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 173 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 174 BENELUX INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 175 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 176 BENELUX HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 177 BENELUX PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 178 BENELUX PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 179 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 180 GSA & BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 181 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 182 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 183 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 184 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 185 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 186 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 187 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 188 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 189 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 191 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 192 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 193 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 194 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 195 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 196 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 197 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 198 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 199 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 200 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 201 GERMANY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 202 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 204 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 205 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 206 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 207 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 208 GERMANY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 209 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 210 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 211 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 212 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 213 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 214 GERMANY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 215 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 216 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 217 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 218 GERMANY BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 219 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 220 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 221 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 222 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 223 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 224 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 225 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 227 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 228 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 229 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 230 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 231 GERMANY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 232 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 233 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 234 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 235 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 236 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 237 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 238 GERMANY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 239 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 240 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 241 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 242 GERMANY VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 243 GERMANY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 244 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 245 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 246 GERMANY DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 247 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 248 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 249 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 250 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 251 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 252 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 253 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 254 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 255 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 256 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 257 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 258 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 259 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 260 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 261 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 262 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 263 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 264 GERMANY INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 266 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 267 GERMANY HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 268 GERMANY PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 269 GERMANY PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 270 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 271 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 272 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 273 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 274 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 275 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 276 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 277 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 278 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 279 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 280 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 281 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 282 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 283 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 284 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 285 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 286 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 287 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 288 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 289 NETHERLANDS INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 290 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 291 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 292 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 293 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 294 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 295 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 296 NETHERLANDS CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 297 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 298 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 299 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 300 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 301 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 302 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 303 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 304 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 305 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 306 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 307 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 308 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 309 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 310 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 311 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 312 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 313 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 314 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 315 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 316 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 317 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 318 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 319 NETHERLANDS PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 320 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 321 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 322 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 323 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 324 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 325 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 326 NETHERLANDS COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 327 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 328 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 329 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 330 NETHERLANDS VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 331 NETHERLANDS DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 332 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 333 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 334 NETHERLANDS DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 335 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 336 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 337 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 338 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 339 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 340 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 341 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 342 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 343 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 344 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 345 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 346 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 347 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 348 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 349 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 350 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 351 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 352 NETHERLANDS INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 353 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 354 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 355 NETHERLANDS HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 356 NETHERLANDS PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 357 NETHERLANDS PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 358 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 359 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 360 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 361 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 362 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 363 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 364 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 365 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 366 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 367 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 368 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 369 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 370 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 371 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 372 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 373 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 374 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 375 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 376 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 377 SWITZERLAND INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 378 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 379 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 380 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 381 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 382 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 383 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 384 SWITZERLAND CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 385 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 386 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 387 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 388 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 389 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 390 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 391 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 392 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 393 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 394 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 395 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 396 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 397 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 398 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 399 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 400 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 401 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 402 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 403 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 404 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 405 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 406 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 407 SWITZERLAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 408 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 409 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 410 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 411 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 412 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 413 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 414 SWITZERLAND COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 415 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 416 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 417 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 418 SWITZERLAND VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 419 SWITZERLAND DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 420 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 421 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 422 SWITZERLAND DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 423 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 424 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 425 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 426 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 427 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 428 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 429 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 430 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 431 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 432 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 433 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 434 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 435 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 436 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 437 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 438 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 439 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 440 SWITZERLAND INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 441 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 442 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 443 SWITZERLAND HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 444 SWITZERLAND PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 445 SWITZERLAND PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 446 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 447 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 448 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 449 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 450 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 451 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 452 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 453 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 454 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 455 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 456 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 457 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 458 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 459 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 460 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 461 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 462 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 463 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 464 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 465 BELGIUM INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 466 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 467 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 468 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 469 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 470 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 471 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 472 BELGIUM CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 473 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 474 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 475 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 476 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 477 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 478 BELGIUM BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 479 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 480 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 481 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 482 BELGIUM BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 483 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 484 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 485 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 486 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 487 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 488 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 489 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 490 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 491 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 492 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 493 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 494 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 495 BELGIUM PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 496 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 497 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 498 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 499 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 500 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 501 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 502 BELGIUM COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 503 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 504 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 505 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 506 BELGIUM VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 507 BELGIUM DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 508 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 509 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 510 BELGIUM DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 511 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 512 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 513 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 514 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 515 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 516 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 517 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 518 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 519 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 520 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 521 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 522 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 523 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 524 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 525 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 526 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 527 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 528 BELGIUM INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 529 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 530 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 531 BELGIUM HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 532 BELGIUM PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 533 BELGIUM PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 534 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 535 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 536 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 537 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 538 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 539 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 540 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 541 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 542 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 543 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 544 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 545 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 546 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 547 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 548 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 549 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 550 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 551 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 552 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 553 AUSTRIA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 554 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 555 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 556 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 557 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 558 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 559 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 560 AUSTRIA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 561 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 562 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 563 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 564 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 565 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 566 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 567 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 568 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 569 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 570 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 571 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 572 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 573 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 574 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 575 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 576 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 577 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 578 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 579 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 580 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 581 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 582 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 583 AUSTRIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 584 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 585 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 586 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 587 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 588 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 589 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 590 AUSTRIA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 591 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 592 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 593 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 594 AUSTRIA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 595 AUSTRIA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 596 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 597 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 598 AUSTRIA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 599 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 600 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 601 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 602 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 603 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 604 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 605 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 606 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 607 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 608 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 609 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 610 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 611 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 612 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 613 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 614 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 615 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 616 AUSTRIA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 617 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 618 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 619 AUSTRIA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 620 AUSTRIA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 621 AUSTRIA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 622 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 623 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 624 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 625 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 626 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 627 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 628 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 629 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 630 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 631 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 632 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 633 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 634 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 635 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 636 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 637 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 638 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 639 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 640 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 641 LUXEMBOURG INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 642 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 643 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 644 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 645 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 646 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 647 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 648 LUXEMBOURG CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 649 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 650 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 651 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 652 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 653 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 654 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 655 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 656 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 657 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 658 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 659 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 660 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 661 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 662 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 663 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 664 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 665 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 666 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 667 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 668 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 669 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 670 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 671 LUXEMBOURG PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 672 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 673 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 674 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 675 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 676 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 677 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 678 LUXEMBOURG COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 679 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 680 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 681 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 682 LUXEMBOURG VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 683 LUXEMBOURG DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 684 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 685 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 686 LUXEMBOURG DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 687 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 688 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 689 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 690 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 691 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 692 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 693 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 694 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 695 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 696 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 697 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 698 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 699 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 700 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 701 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 702 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 703 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 704 LUXEMBOURG INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 705 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 706 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 707 LUXEMBOURG HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 708 LUXEMBOURG PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 709 LUXEMBOURG PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 710 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

그림 목록

FIGURE 1 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION

FIGURE 2 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DATA TRIANGULATION

FIGURE 3 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DROC ANALYSIS

FIGURE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 6 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 7 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION

FIGURE 11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)

FIGURE 12 BEMELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)

FIGURE 13 GSA POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY

FIGURE 14 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY

FIGURE 15 STRATEGIC DECISIONS

FIGURE 16 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE GSA POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 17 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 18 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GSA POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 19 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 20 DROC ANALYSIS

FIGURE 21 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE PREVALENCE (PERCENTAGE)

FIGURE 22 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE (IN MILLION)

FIGURE 23 SUBSTANCE USE BEHAVIOURS AMONG 15-YEAR-OLDS IN 2022 (SELF-REPORTED PREVALENCE)

FIGURE 24 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024

FIGURE 25 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 26 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 27 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 28 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024

FIGURE 29 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)

FIGURE 30 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)

FIGURE 31 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE

FIGURE 32 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024

FIGURE 33 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)

FIGURE 34 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)

FIGURE 35 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 36 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024

FIGURE 37 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)

FIGURE 38 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)..

FIGURE 39 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 40 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024

FIGURE 41 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)

FIGURE 42 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)

FIGURE 43 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE

FIGURE 44 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 45 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)

FIGURE 46 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)

FIGURE 47 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 48 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024

FIGURE 49 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 50 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 51 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 52 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024

FIGURE 53 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)

FIGURE 54 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)

FIGURE 55 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 56 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024

FIGURE 57 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)

FIGURE 58 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)

FIGURE 59 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE

FIGURE 60 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024

FIGURE 61 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)

FIGURE 62 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)

FIGURE 63 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 64 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024

FIGURE 65 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)

FIGURE 66 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)

FIGURE 67 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE

FIGURE 68 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 69 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)

FIGURE 70 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)

FIGURE 71 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 72 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)

FIGURE 73 GSA POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)

FIGURE 74 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY SHARE 2024 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

시장은 GSA 및 베네룩스 현장진단(POCT) 시장, 제품 유형별(포도당 모니터링 제품, 감염성 질환 검사 제품, 심장대사 모니터링 제품, 임신 및 생식력 검사 제품, 혈액학 검사 제품, 응고 모니터링 제품, 약물 남용(DOA) 검사 제품, 요분석 검사 제품, 콜레스테롤 검사 제품, 종양/암 마커 검사 제품, 분변 잠복 검사 제품 및 기타), 플랫폼별(측면 유동 분석/면역크로마토그래피 검사, 면역 분석, 딥스틱, 분자 진단, 임상 화학 분석, 미세유체역학, 혈액학, 기타), 응용 분야별(혈당, 감염성 질환, 생체 신호 모니터링, 심장 모니터링, 응고, 혈액학, 비침습적 SpO2 모니터링, 수혈, 비침습적 PCO2 모니터링, 전혈 분석, 기타), 처방 방식별(처방 기반 테스트 및 일반 의약품 테스트), 최종 사용자별(병원, 가정 간병, 진료소, 실험실, 진단 센터, 병리학 실험실, 외래 수술 센터, 노인 요양 센터, 기타), 유통 채널별(직접 입찰, 소매 판매, 온라인 판매 및 기타) - 2032년까지의 산업 동향 및 예측 기준으로 세분화됩니다.
GSA 및 베넬룩스 현장진료검사(POCT) 시장의 시장 규모는 2024년에 3.63 USD Billion USD로 평가되었습니다.
GSA 및 베넬룩스 현장진료검사(POCT) 시장는 2025년부터 2032년까지 연평균 성장률(CAGR) 12.1%로 성장할 것으로 예상됩니다.
시장 내 주요 기업으로는 F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers AG, Bio-Rad Laboratories Inc., BIOMÉRIEUX가 포함됩니다.

관련 페이지 탐색

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future